BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Concord Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543960
ISIN Demat
INE338H01029
Book Value (Rs)
193.0629905
NSE Symbol
CONCORDBIO
Divident Yield %
0.51
Market Cap
(Rs In Cr.)
15,629
P/E (TTM)
54.96
EPS (TTM)
27.18
Face Value
(Rs)
1
Back
Concord Biotech consolidated net profit rises 32.84% in the June 2026 quarter
01-Aug-26   Hrs IST

Net profit of Concord Biotech rose 32.84% to Rs 58.53 crore in the quarter ended June 2026 as against Rs 44.06 crore during the previous quarter ended June 2025. Sales rose 26.23% to Rs 257.49 crore in the quarter ended June 2026 as against Rs 203.99 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales257.49203.99 26
OPM %31.9930.10 -
PBDT96.4476.51 26
PBT78.3458.73 33
NP58.5344.06 33

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)